Impact of Abnormal Leukocyte Count in the Pathophysiology of Sickle Cell Anemia

References

• Stamatoyannopoulos G. The molecular basis of hemoglobin disease. Annu Rev Genet. 2003;6:47–70. doi:10.1146/annurev.ge06120172000403
   Google Scholar
• Ballas SK, Kesen MR, Goldberg MF, et al. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. Sci World J. 2012;2012:55. PMC3415156.
   Google Scholar
• Solovieff N, Hartley SW, Baldwin CT, et al. Ancestry of African Americans with sickle cell disease. Blood Cells Mol Dis. 2011;47(1):41. PMC3116635. doi:10.1016/j.bcmd.2011.04.002
   PubMed Web of Science ®Google Scholar
• Curtis SA, Danda N, Etzion Z, Cohen HW, Billett HH, Lam W. Elevated steady state WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia. PLoS One. 2015;10(8):e0133116. doi:10.1371/journal.pone.0133116
   PubMed Web of Science ®Google Scholar
• Ahmed AE, Ali YZ, Al-Suliman AM, et al. The prevalence of abnormal leukocyte count, and its predisposing factors, in patients with sickle cell disease in Saudi Arabia. J Blood Med. 2017;8(185):185–191. PMC5661844. doi:10.2147/JBM.S148463
   PubMedGoogle Scholar
• Zhang D, Xu C, Manwani D, Frenette PS. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood. 2016;127(7):801–809. doi:10.1182/blood-2015-09-618538
   PubMed Web of Science ®Google Scholar
• Akinbami A, Dosunmu A, Adediran A, Oshinaike O, Adebola P, Arogundade O. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5(1):1–6. doi:10.1186/1756-0500-5-396
   PubMedGoogle Scholar
• Buchanan GR, Glader BE. Leukocyte counts in children with sickle cell disease: comparative values in the steady state, vaso-occlusive crisis, and bacterial infection. Am J Dis Child. 1978;132(4):396–398. doi:10.1001/archpedi.1978.02120290068013
   PubMedGoogle Scholar
• Okpala I. The intriguing contribution of white blood cells to sickle cell disease – a red cell disorder. Blood Rev. 2004;18(1):65–73. doi:10.1016/S0268-960X(03)00037-7
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269. doi:10.7326/0003-4819-151-4-200908180-00135
   PubMed Web of Science ®Google Scholar
• Wun T. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease. Hematology. 2000;5(5):403–412. doi:10.1080/10245332.2000.11746536
   PubMedGoogle Scholar
• Okpala I, Daniel Y, Haynes R, Odoemene D, Goldman J. Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. Eur J Haematol. 2002;69(3):135–144. doi:10.1034/j.1600-0609.2002.02775.x
   PubMed Web of Science ®Google Scholar
• Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci U S A. 2002;99(5):3047–3051. doi:10.1073/pnas.052522799
   PubMed Web of Science ®Google Scholar
• Hedo C, Aken’ova Y, Okpala I, Salimonu L. Serum immunoglobulin (G, A and M) classes and IgG subclasses in sickle cell anaemia. APMIS. 1993;101(5):353–357. doi:10.1111/j.1699-0463.1993.tb00121.x
   PubMed Web of Science ®Google Scholar
• Anyaegbu CC, Okpala IE, Aken’ova AY, Salimonu LS. Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia. APMIS. 1999;107(7):699–702. doi:10.1111/j.1699-0463.1999.tb01463.x
   PubMed Web of Science ®Google Scholar
• Hedo CC, Aken’ova YA, Okpala IE, Durojaiye AO, Salimonu LS. Acute phase reactants and severity of homozygous sickle cell disease. J Intern Med. 1993;233(6):467–470. doi:10.1111/j.1365-2796.1993.tb01000.x
   PubMed Web of Science ®Google Scholar
• Anyaegbu CC, Okpala IE, Akren’Ova A, Salimonu S. Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA). Eur J Haematol. 1998;60(4):267–268. doi:10.1111/j.1600-0609.1998.tb01036.x
   PubMed Web of Science ®Google Scholar
• Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med. 1995;332(20):1317–1322. doi:10.1056/NEJM199505183322001
   PubMed Web of Science ®Google Scholar
• Frenette PS. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol. 2002;9(2):101–106. doi:10.1097/00062752-200203000-00003
   PubMed Web of Science ®Google Scholar
• Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost. 1999;81(01):1–7. doi:10.1055/s-0037-1614407
   PubMedGoogle Scholar
• Silverstein RL, Asch AS, Nachman RL. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest. 1989;84(2):546–552. doi:10.1172/JCI114197
   PubMed Web of Science ®Google Scholar
• Walcheck B, Moore KL, McEver RP, Kishimoto TK. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest. 1996;98(5):1081–1087. doi:10.1172/JCI118888
   PubMed Web of Science ®Google Scholar
• Tan P, Luscinskas FW, Homer-Vanniasinkam S. Cellular and molecular mechanisms of inflammation and thrombosis. Eur J Vasc Endovasc Surg. 1999;17(5):373–389. doi:10.1053/ejvs.1998.0759
   PubMed Web of Science ®Google Scholar
• Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood. 2000;96(7):2451–2459. doi:10.1182/blood.V96.7.2451
   PubMed Web of Science ®Google Scholar
• Stewart West M, Wethers D, Smith J, Steinberg M. The cooperative study of sickle cell disease. Laboratory profile of sickle cell disease: a cross-sectional analysis. The cooperative study of sickle cell disease. J Clin Epidemiol. 1992;45(8):893–909. doi:10.1016/0895-4356(92)90073-V
   PubMed Web of Science ®Google Scholar
• Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342(2):83–89. doi:10.1056/NEJM200001133420203
   PubMed Web of Science ®Google Scholar
• Platt OS. The acute chest syndrome of sickle cell disease. N Engl J Med. 2000;342(25):1904–1907. doi:10.1056/NEJM200006223422510
   PubMed Web of Science ®Google Scholar
• Hofstra TC, Kalra VK, Meiselman HJ, Coates TD. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. Blood. 1996;87(10):4440–4447. doi:10.1182/blood.V87.10.4440.bloodjournal87104440
   PubMed Web of Science ®Google Scholar
• Mendoza E, Gutgsell N, Temple JD, Issitt P. Monocyte phagocytic activity in sickle cell disease. Acta Haematol. 1991;85(4):199–201. doi:10.1159/000204892
   PubMed Web of Science ®Google Scholar
• Gawaz M, Fateh‐moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest. 1995;25(11):843–851. doi:10.1111/j.1365-2362.1995.tb01694.x
   PubMed Web of Science ®Google Scholar
• Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996;97(6):1525–1534. doi:10.1172/JCI118575
   PubMed Web of Science ®Google Scholar
• Dias-Da-Motta PM, Arruda VR, Muscará MN, et al. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br J Haematol. 1996;93(2):333–340. doi:10.1046/j.1365-2141.1996.4951036.x
   PubMed Web of Science ®Google Scholar
• Adler BK, Salzman DE, Carabasi MH, Vaughan WP, Reddy VVB, Prchal JT. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood. 2001;97(10):3313–3314. doi:10.1182/blood.V97.10.3313
   PubMed Web of Science ®Google Scholar
• Abboud M, Laver J, Blau CA. Granulocytosis causing sickle-cell crisis. Lancet. 1998;351(9107):959. doi:10.1016/S0140-6736(05)60614-9
   PubMed Web of Science ®Google Scholar
• Wei A, Grigg A. Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia. Blood. 2001;97(12):3998–3999. doi:10.1182/blood.V97.12.3998
   PubMed Web of Science ®Google Scholar
• Wali Y, Beshlawi I, Fawaz N, et al. Coexistence of sickle cell disease and severe congenital neutropenia: first impressions can be deceiving. Eur J Haematol. 2012;89(3):245–249. doi:10.1111/j.1600-0609.2012.01827.x
   PubMed Web of Science ®Google Scholar
• Saleh AW, Hillen HFP, Duits AJ. Levels of endothelial, neutrophil, and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy. Acta Haematol. 1999;102(1):31–37. doi:10.1159/000040964
   PubMed Web of Science ®Google Scholar
• Almeida CB, Scheiermann C, Jang JE, et al. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice. Blood. 2012;120(14):2879–2888. doi:10.1182/blood-2012-02-409524
   PubMed Web of Science ®Google Scholar
• Barazia A, Li J, Kim K, Shabrani N, Cho J. Hydroxyurea with AKT2 inhibition decreases vaso-occlusive events in sickle cell disease mice. Blood. 2015;126(22):2511–2517. doi:10.1182/blood-2015-02-626234
   PubMed Web of Science ®Google Scholar
• Charache S, Barton FB, Moore RD, et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent. The multicenter study of hydroxyurea in sickle cell anemia. Medicine. 1996;75(6):300–326. doi:10.1097/00005792-199611000-00002
   PubMed Web of Science ®Google Scholar
• Benkerrou M, Delarche C, Brahimi L, et al. Hydroxyurea corrects the dysregulated L-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia. Blood. 2002;99(7):2297–2303. doi:10.1182/blood.V99.7.2297
   PubMed Web of Science ®Google Scholar
• Safaya S, Steinberg MH, Klings ES. Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of the NF-κB signaling pathway. Mol Immunol. 2012;50(1–2):117–123. doi:10.1016/j.molimm.2011.12.012
   PubMed Web of Science ®Google Scholar
• Keegan PM, Surapaneni S, Platt MO. Sickle cell disease activates peripheral blood mononuclear cells to induce cathepsins k and v activity in endothelial cells. Anemia. 2012;2012:1–7. doi:10.1155/2012/201781
   Google Scholar
• Ivetic A, Green HLH, Hart SJ. L-selectin: a major regulator of leukocyte adhesion, migration and signaling. Front Immunol. 2019;10(May). PMC6527602. doi:10.3389/fimmu.2019.01068
   Web of Science ®Google Scholar
• Panés J, Perry M, Granger DN. Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol. 1999;126(3):537. PMC1565837, doi:10.1038/sj.bjp.0702328
   PubMed Web of Science ®Google Scholar
• Johnson C, Telen MJ. Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease. Haematologica. 2008;93(4):481–485. doi:10.3324/haematol.12734
   PubMed Web of Science ®Google Scholar